Ustekinumab for the treatment of adults with moderate to severe psoriasis

Psoriasis - ustekinumab: appraisal consultation

This appraisal consultation opened on Wednesday 20 May and will close at 5pm on Wednesday 10 June 2009.

This page was last updated: 30 March 2010